Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRockwood Strat. Regulatory News (RKW)

Share Price Information for Rockwood Strat. (RKW)

Share Price is delayed by 15 minutes
Get Live Data
322.50    0.00 (0.00%)
Bid:
317.00
Ask:
326.00
Spread: 9.00 (2.839%)
Market Cap: £182.89m
RKW Live PriceLast checked at - London Stock Exchange

Intraday Rockwood Strat. Share Chart

Kepler Trust Intelligence: New Research

12 Dec 2025 07:00

RNS Number : 2097L
Rockwood Strategic PLC
12 December 2025
 

Rockwood Strategic: New Research

12/12/2025

RKW has continued to deliver double-digit returns…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAZZMMZGMRGKZM
Date   Source Headline
3rd Jun 20267:00 amRNSIssue of Equity and TVR
1st Jun 20264:54 pmRNSNet Asset Value(s)
1st Jun 20267:00 amRNSIssue of Equity and TVR
29th May 20267:00 amRNSIssue of Equity
26th May 20264:18 pmRNSNet Asset Value(s)
18th May 20265:22 pmRNSNet Asset Value(s)
15th May 20267:00 amRNSIssue of Equity and TVR
14th May 20267:00 amRNSIssue of Equity and TVR
11th May 20264:10 pmRNSNet Asset Value(s)
8th May 20267:00 amRNSInvestor Presentation
5th May 20262:32 pmRNSNet Asset Value(s)
1st May 20263:57 pmRNSNet Asset Value(s)
27th Apr 20264:01 pmRNSNet Asset Value(s)
22nd Apr 20267:00 amRNSIssue of Equity and TVR
20th Apr 20262:58 pmRNSNet Asset Value(s)
20th Apr 20267:00 amRNSIssue of Equity and TVR
13th Apr 20263:12 pmRNSNet Asset Value(s)
7th Apr 20264:16 pmRNSNet Asset Value(s)
7th Apr 20262:00 pmRNSDirector Declaration
1st Apr 20264:54 pmRNSNet Asset Value(s)
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20266:24 pmRNSNet Asset Value(s)
25th Mar 20267:00 amRNSIssue of Equity and TVR
19th Mar 20267:00 amRNSDirector/PDMR Shareholding
18th Mar 202610:30 amRNSDirector/PDMR Shareholding
16th Mar 20263:49 pmRNSNet Asset Value(s)
11th Mar 20267:00 amRNSIssue of Equity and TVR
9th Mar 20262:51 pmRNSNet Asset Value(s)
9th Mar 20267:00 amRNSIssue of Equity and TVR
4th Mar 20264:22 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSIssue of Equity and TVR
2nd Mar 20264:44 pmRNSNet Asset Value(s)
2nd Mar 20267:00 amRNSIssue of Equity and TVR
27th Feb 20267:00 amRNSIssue of Equity and TVR
26th Feb 20267:00 amRNSIssue of Equity and TVR
25th Feb 20267:00 amRNSIssue of Equity and TVR
23rd Feb 20263:34 pmRNSNet Asset Value(s)
23rd Feb 20267:00 amRNSIssue of Equity and TVR
19th Feb 20267:00 amRNSIssue of Equity and TVR
18th Feb 20267:00 amRNSIssue of Equity and TVR
16th Feb 20264:02 pmRNSNet Asset Value(s)
16th Feb 20267:00 amRNSIssue of Equity and TVR
11th Feb 20267:00 amRNSIssue of Equity and TVR
10th Feb 20267:00 amRNSIssue of Equity and TVR
9th Feb 20263:49 pmRNSNet Asset Value(s)
5th Feb 20267:00 amRNSIssue of Equity and TVR
4th Feb 20267:00 amRNSIssue of Equity and TVR
3rd Feb 20267:00 amRNSIssue of Equity and TVR
2nd Feb 20263:29 pmRNSNet Asset Value(s)
26th Jan 20263:27 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.